A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis

Journal of Lipid Research

Volumn 42, Issue 4, 2001, Pages 545-552

  Garber, D W ^a   Datta, G ^a   Chaddha, M ^a   Palgunachari, M N ^a   Hama, S Y ^a   Navab, M ^a   Fogelman, A M ^a   Segrest, J P ^a   Anantharamaiah, G M ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Aorta; Cholesterol; Lipoproteins; Metabolism

Indexed keywords

5 F; ACETYLASPARTYLTRYPTOPHYLLEUCYLLYSYLALANYLPHENYLALANYLTYROSYLASPARTYLLYSYLVA LYLPHENYLALANYLGLUTAMYLLYSYLPHENYLALANYLLYSYLGLUTAMYLPHENYLALANYLPHENYLALANINAMI DE; APOLIPOPROTEIN A1; CHOLESTEROL; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; AORTA; ARTICLE; ATHEROSCLEROSIS; CHEMOTAXIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LIPID DIET; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; BODY WEIGHT; COCULTURE TECHNIQUES; DIET, ATHEROGENIC; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KINETICS; LIPOPROTEINS; MICE; MICE, INBRED C57BL; PEPTIDES; RANDOM ALLOCATION;

EID: 0035059743     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. High density lipoprotein cholesterol and mortality. The Framingham heart study
2. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
3. Structural models of apolipoprotein A-I
4. A molecular theory for protein-lipid interactions in plasma lipoproteins
5. Amphipathic helix motif: Classes and properties
6. Studies of synthetic peptide analogs of the amphipathic helix
7. Binding of apolipoprotein A-I model peptides to lipid bilayers
8. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol
9. The influence of apolipoprotein structure on the efflux of cellular cholesterol to high density lipoprotein
10. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function
11. Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties
12. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Step 1
13. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Steps 2 and 3
14. Synthetic peptide analogs of apolipoproteins
15. In vivo protection against endotoxin by plasma HDL
16. Effect of end group blockage on the properties of a class A amphipathic helical peptide
17. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I
18. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
19. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
20. milano on aortic atherosclerosis in apolipoprotein E-deficient mice
21. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice
22. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly
23. Chromatographic methods for quantification of apolipoprotein A-I
24. The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations
25. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid
26. A sensitive and convenient method for lipoprotein profile analysis of individual mouse samples
27. Enzyme immunoassay ELISA and EMST
28. Effect of the arrangement of tandem repeating units of Class A amphipathic alpha helixes on lipid interaction
29. Structural and functional properties of human and mouse apolipoprotein A-I
30. Delivery system design for improvement of intestinal adsorption of peptide drugs
31. Current concepts in intestinal peptide adsorption
32. Antiatherogenic properties of a model amphipathic helical peptide: Studies in transgenic mice